OK Biotech Co Ltd
TWSE:4155

Watchlist Manager
OK Biotech Co Ltd Logo
OK Biotech Co Ltd
TWSE:4155
Watchlist
Price: 14.65 TWD Market Closed
Market Cap: NT$2.1B

Relative Value

The Relative Value of one OK Biotech Co Ltd stock under the Base Case scenario is hidden TWD. Compared to the current market price of 14.65 TWD, OK Biotech Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OK Biotech Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
OK Biotech Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TW
OK Biotech Co Ltd
TWSE:4155
2.1B TWD 1.3 29.9 19.3 36
JP
Hoya Corp
TSE:7741
8.7T JPY 9.7 41.4 25.7 30.7
CH
Alcon AG
SIX:ALC
31.5B CHF 3.9 38.4 20.1 39
US
Medline Inc
NASDAQ:MDLN
37.3B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
122.5B DKK 4.4 33.6 15.5 18.4
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD 3 32 14.5 18.4
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 2.8 30 18 29.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44B CNY 9.7 26.8 24.1 24.1
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.6 19.5 92.2
CH
Ypsomed Holding AG
SIX:YPSN
4.6B CHF 5.8 23.7 15.3 20.8
KR
HLB Inc
KOSDAQ:028300
7.5T KRW 86.3 -31.7 -79.2 -74.9
P/E Multiple
Earnings Growth PEG
TW
OK Biotech Co Ltd
TWSE:4155
Average P/E: 32
29.9
N/A N/A
JP
Hoya Corp
TSE:7741
41.4
13%
3.2
CH
Alcon AG
SIX:ALC
38.4
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
33.6
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
32
27%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
30
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.8
9%
3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.6 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
23.7
32%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -31.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TW
OK Biotech Co Ltd
TWSE:4155
Average EV/EBITDA: 19.1
19.3
N/A N/A
JP
Hoya Corp
TSE:7741
25.7
11%
2.3
CH
Alcon AG
SIX:ALC
20.1
8%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.5
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14.5
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
18
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.1
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.5
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
15.3
21%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -79.2 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
TW
OK Biotech Co Ltd
TWSE:4155
Average EV/EBIT: 34.3
36
N/A N/A
JP
Hoya Corp
TSE:7741
30.7
N/A N/A
CH
Alcon AG
SIX:ALC
39
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.4
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
18.4
16%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29.3
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.1
11%
2.2
CA
Bausch + Lomb Corp
NYSE:BLCO
92.2
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
20.8
29%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -74.9 N/A N/A